Quick Answer
Organon & Co. reported Total Assets of $12.87 billion for the year ending 2025.
- Organon & Co. showed a decrease of -1.8% in Total Assets from 2024 to 2025.
- This data is from Organon & Co.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $9.64 billion | Q2 2021: $10.91 billion | Q3 2021: $11.34 billion | Q1 2022: $10.60 billion | Q2 2022: $10.61 billion | Q3 2022: $10.44 billion | Q1 2023: $10.76 billion | Q2 2023: $10.98 billion | Q3 2023: $11.01 billion | Q1 2024: $11.89 billion | Q2 2024: $12.15 billion | Q3 2024: $12.75 billion | Q1 2025: $13.16 billion | Q2 2025: $13.50 billion | Q3 2025: $13.55 billion.
- Over the full 6 years of available data (2020 to 2025), Organon & Co.'s Total Assets has grown by 27.3%.
- Historical annual values: Fiscal year 2025: $12.87 billion | Fiscal year 2024: $13.10 billion | Fiscal year 2023: $12.06 billion | Fiscal year 2022: $10.96 billion | Fiscal year 2021: $10.68 billion | Fiscal year 2020: $10.11 billion.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: